Position in TENX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,429,388
+$1,290,286 QoQ
Shares Held
339,549
0.0% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TENX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BVF INC/IL holds $3,049,190,615 across 38 Biotechnology names. TENX ranks #36 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
|
5,502,710 | $458,320,715 | |
| 2 | MLTX |
MoonLake Immunotherapeutics
|
16,001,284 | $298,263,933 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
2,856,782 | $277,822,049 | |
| 4 | NKTR |
Nektar Therapeutics
|
2,559,595 | $184,162,860 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
3,459,358 | $166,741,055 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,584,727 | $146,397,080 | |
| 7 | GHRS |
GH Research PLC
|
8,650,158 | $121,621,221 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
960,989 | $119,787,278 |
All Filings in TENX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,429,388 | 339,549 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,139,102 | 339,549 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,583,967 | 339,549 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,955,802 | 339,549 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,224,045 | 339,549 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,101,808 | 339,549 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,174,839 | 339,549 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||